Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05133362 · ClinicalTrials.gov registry record · NA
Effects of Backward Gait Training With Exoskeleton on Motor Functions
A NA study, sponsored by Alvernia University.
- Terminated
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT05133362: Clinical Trial NA study, sponsored by Alvernia University.
NCT05133362 is a NA study that was terminated before completion, run by Alvernia University. The registered enrollment target is 9 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05133362, a NA study, was terminated before completion, sponsored by Alvernia University.
- TERMINATED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
The proposed study aims to optimize patient outcomes and treatment intervention using a robotic exoskeleton in adults with cerebrovascular accidents (CVA, stroke) by investigating the following: AIM 1 is to investigate the effect of backward gait training with exoskeleton on motor function. AIM 2 is to investigate the effect of backward gait training with exoskeleton on depression. AIM 3 is to investigate the impact of social determinants of health and depression on patient adherence to physical therapy.
Primary Outcome
Changes from baseline backward gait speed measured by 3-Meter Backwards Walk Test at post-intervention
Interventions
- DEVICE Gait training with EksoNR
- PROCEDURE Backward gait training with EksoNR
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2022-08-25 |
| Est. Completion | 2024-09-30 |
| Phase | NA |
Why NCT05133362 stopped before completion
NCT05133362 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Gait training with EksoNR is the first listed.
NCT05133362 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05133362 about?
NCT05133362 is a clinical study titled "Effects of Backward Gait Training With Exoskeleton on Motor Functions". The proposed study aims to optimize patient outcomes and treatment intervention using a robotic exoskeleton in adults with cerebrovascular accidents (CVA, stroke) by investigating the following: AIM 1 is to investigate the effect of backward gait training with exoskeleton on motor function. AIM 2 i...
What is the current status of trial NCT05133362?
This trial is currently terminated. It is a NA study. The enrollment target is 9 participants. The study started on 2022-08-25. Estimated completion is 2024-09-30.
What interventions are being tested in trial NCT05133362?
The interventions under investigation include: Gait training with EksoNR (DEVICE), Backward gait training with EksoNR (PROCEDURE).
Who is sponsoring clinical trial NCT05133362?
This trial is sponsored by Alvernia University, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05133362's enrollment target sits among peer trials
9 1975th of 2000 higher than 25 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI